$5.76
2.86%
Nasdaq, Sep 25, 04:00 pm EDT. Closed.
ISIN
CA74319B5027
Symbol
PROF

Profound Medical Corp Target price 2026 - Analyst rating & recommendation

Profound Medical Corp Classifications & Recommendation

Buy
80%
Hold
20%

Profound Medical Corp Price Target

Target Price $8.29
Price $5.76
Potential
Number of Estimates 3
3 Analysts have issued a price target Profound Medical Corp 2027 . The average Profound Medical Corp target price is $8.29. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 5 analysts: 4 Analysts recommend Profound Medical Corp to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Profound Medical Corp stock has an average upside potential 2027 of . Most analysts recommend the Profound Medical Corp stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Million $ 16.10 25.55
50.75% 58.71%
EBITDA Margin -252.73% -111.07%
15.99% 56.05%
Net Margin -264.41% -124.90%
1.51% 52.76%

5 Analysts have issued a sales forecast Profound Medical Corp 2026 . The average Profound Medical Corp sales estimate is

$25.6m
unlock
. This is
33.86% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$26.8m 40.26%
unlock
, the lowest is
$24.6m 28.85%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $16.1m 50.75%
2026
$25.6m 58.71%
unlock
2027
$43.3m 69.43%
unlock
2028
$80.6m 86.12%
unlock
2029
$107m 33.36%
unlock
2030
$142m 31.97%
unlock
2031
$174m 22.37%
unlock
2032
$207m 19.17%
unlock
2033
$238m 15.24%
unlock

4 Analysts have issued an Profound Medical Corp EBITDA forecast 2026. The average Profound Medical Corp EBITDA estimate is

$-28.4m
unlock
. This is
18.63% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-29.4m 15.71%
unlock
, the lowest is
$-27.6m 20.77%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $-40.7m 26.64%
2026
$-28.4m 30.25%
unlock
2027
$-21.3m 25.09%
unlock
2028
$16.1m 175.70%
unlock
2029
$39.8m 147.05%
unlock
2030
$59.1m 48.73%
unlock
2031
$75.5m 27.66%
unlock
2032
$95.1m 26.02%
unlock
2033
$116m 21.50%
unlock

EBITDA Margin

2025 -252.73% 15.99%
2026
-111.07% 56.05%
unlock
2027
-49.11% 55.78%
unlock
2028
19.97% 140.66%
unlock
2029
37.00% 85.28%
unlock
2030
41.70% 12.70%
unlock
2031
43.50% 4.32%
unlock
2032
46.00% 5.75%
unlock
2033
48.50% 5.43%
unlock

5 Profound Medical Corp Analysts have issued a net profit forecast 2026. The average Profound Medical Corp net profit estimate is

$-31.9m
unlock
. This is
2.56% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-31.9m 2.72%
unlock
, the lowest is
$-32.2m 1.62%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $-42.6m 53.02%
2026
$-31.9m 25.04%
unlock
2027
$-27.7m 13.29%
unlock
2028
$4.8m 117.35%
unlock
2029
$26.2m 446.04%
unlock
2030
$39.9m 52.08%
unlock
2031
$51.3m 28.75%
unlock
2032
$65.0m 26.60%
unlock
2033
$79.0m 21.58%
unlock

Net Margin

2025 -264.41% 1.51%
2026
-124.90% 52.76%
unlock
2027
-63.91% 48.83%
unlock
2028
5.95% 109.31%
unlock
2029
24.39% 309.92%
unlock
2030
28.10% 15.21%
unlock
2031
29.57% 5.23%
unlock
2032
31.41% 6.22%
unlock
2033
33.14% 5.51%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ -1.41 -0.87
25.89% 38.30%
P/E negative
EV/Sales 6.86

5 Analysts have issued a Profound Medical Corp forecast for earnings per share. The average Profound Medical Corp EPS is

$-0.87
unlock
. This is
3.33% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$-0.88 2.22%
unlock
, the lowest is
$-0.87 3.33%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $-1.41 25.89%
2026
$-0.87 38.30%
unlock
2027
$-0.76 12.64%
unlock
2028
$0.13 117.11%
unlock
2029
$0.72 453.85%
unlock
2030
$1.09 51.39%
unlock
2031
$1.40 28.44%
unlock
2032
$1.78 27.14%
unlock
2033
$2.16 21.35%
unlock

P/E ratio

Current -6.22 93.55%
2026
-6.41 3.02%
unlock
2027
-7.39 15.29%
unlock
2028
42.65 677.13%
unlock
2029
7.80 81.71%
unlock
2030
5.13 34.23%
unlock
2031
3.99 22.22%
unlock
2032
3.15 21.05%
unlock
2033
2.59 17.78%
unlock

Based on analysts' sales estimates for 2026, the Profound Medical Corp stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 9.18 15.47%
2026
6.86 25.30%
unlock
2027
4.05 40.98%
unlock
2028
2.17 46.27%
unlock
2029
1.63 25.01%
unlock
2030
1.24 24.23%
unlock
2031
1.01 18.28%
unlock
2032
0.85 16.09%
unlock
2033
0.74 13.22%
unlock

P/S ratio

Current 10.95 4.08%
2026
8.18 25.29%
unlock
2027
4.83 40.98%
unlock
2028
2.59 46.27%
unlock
2029
1.94 25.01%
unlock
2030
1.47 24.22%
unlock
2031
1.20 18.29%
unlock
2032
1.01 16.09%
unlock
2033
0.88 13.21%
unlock

Current Profound Medical Corp Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
LEEDE JONES GABLE
Locked
➜
Locked
Locked Mar 07 2026
LEEDE JONES GABLE
Locked
➜
Locked
Locked Aug 15 2025
LEEDE JONES GABLE
Locked
➜
Locked
Locked May 09 2025
LEEDE JONES GABLE
Locked
➜
Locked
Locked May 08 2025
RAYMOND JAMES LTD.
Locked
➜
Locked
Locked Apr 29 2025
RAYMOND JAMES LTD.
Locked
➜
Locked
Locked Apr 28 2025
RAYMOND JAMES LTD.
Locked
➜
Locked
Locked Mar 05 2025
Analyst Rating Date
Locked
LEEDE JONES GABLE:
Locked
➜
Locked
Mar 07 2026
Locked
LEEDE JONES GABLE:
Locked
➜
Locked
Aug 15 2025
Locked
LEEDE JONES GABLE:
Locked
➜
Locked
May 09 2025
Locked
LEEDE JONES GABLE:
Locked
➜
Locked
May 08 2025
Locked
RAYMOND JAMES LTD.:
Locked
➜
Locked
Apr 29 2025
Locked
RAYMOND JAMES LTD.:
Locked
➜
Locked
Apr 28 2025
Locked
RAYMOND JAMES LTD.:
Locked
➜
Locked
Mar 05 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today